ADA Final Impressions
This year’s version of the annual ADA confab was like past year’s versions full of both hope and trepidation. The data especially for the coming crop of weight loss meds was very compelling. As we predicted long ago not only is CGM becoming the standard for glucose measurement the usage of CGM is moving into the non-diabetic consumer health arena. Yet even with these advancements in drugs and devices one...
You don’t get a second chance at a first impression.
Not sure how many people remember when the 670G received FDA approval, but several organizations hailed the event calling it a new day in diabetes management. As the very first AID system approved by b the FDA everyone thought Medtronic had a runaway hit on their hands. That was everyone but us as we knew the 670G was NOT the best thing since sliced bread and soft soap. The major...
Is this progress?
Walking through the exhibit hall made me wonder what progress if any we have made over the past 30 years. Back then BGM was all the rage, today it’s CGM. Back then insulin pumps were new technology, today they are widely used. Insulins really haven’t changed all that much while the hottest thing today are diabetes drugs which also produce weight loss. The saddest lack of change comes where it...
ADA First Impressions
I know everyone is anxious to get to my thoughts on the Dexcom investor event, but I’d like to begin with some initial thoughts. 1. The exhibit hall is on the small side this year with Abbott and Dexcom battling it out for who’s bigger. 2. Did run across another Omnipod wannabe but this one looks interesting so I’ll check it out and report back. 3. If you’re here in beautiful San Diego,...
Preview of coming attractions
As everyone gets ready to descend upon this beautiful city – and just as an FYI the forecast is next to perfect sunny and mid 70’s the entire show- here’s a preview of coming attractions. 1. Yes, I know it’s obvious, but Lilly and Novo Nordisk will dominate. Lilly already has made news as a poster on their oral GLP-1 was “accidentally” posted on their web site which disappointed investors as...
The Mann Awards
The annual ADA money grab isn’t all about money as the ADA also honors individuals for their contributions to diabetes. According to the ADA website “The ADA’s National Scientific and Health Care Achievement Awards honor those who have made important contributions to diabetes research, prevention, and treatment throughout their career,” said Charles “Chuck" Henderson, CEO of the ADA. “By highlighting the progress being made across the diabetes community, our awardees help...
Enemy of my enemy is my friend
It has been said that politics makes strange bedfellows well the same is true when it comes to gaining broader coverage for drugs and/or medical devices. While Abbott would never publicly admit it, they are eternally grateful for all the heavy lifting done by Dexcom to gain broader CGM coverage. Insulet and Tandem would not exist today if it wasn’t for all the hard work put in my MiniMed getting...